Free shipping on all orders over $ 500

Mozavaptan

Cat. No. M1917
Mozavaptan Structure
Synonym:

OPC-31260

Size Price Availability Quantity
10mg USD 60  USD60 In stock
25mg USD 130  USD130 In stock
50mg USD 180  USD180 In stock
100mg USD 260  USD260 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mozavaptan (OPC-31260) is a novel, orally effective, nonpeptide vasopressin V2 receptor antagonist. The V2 receptor subtype is important in water retention, cardiac remodeling in congestive heart failure (CHF), and renal hemodynamic alterations, and is considered a target for polysystic kidney disease. Mozavaptan (OPC-31260) inhibited the antidiuretic action of exogenously administered AVP in water-loaded, alcohol-anaesthetized rats in a dose-dependent manner. Mozavaptan (OPC-31260) caused a competitive displacement of [3H]-AVP binding to both V1 and V2 receptors with IC50 values of 1.2 ± 0.2 × 10-6 M and 1.4 ± 0.2 × 10-8 M, respectively.

Chemical Information
Molecular Weight 427.53
Formula C27H29N3O2
CAS Number 137975-06-5
Solubility (25°C) DMSO: ≥ 3 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Li-Hua Xu, et al. Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness

[2] Essam Ezzeldin, et al. UPLC/MS-MS assay development for estimation of mozavaptan in plasma and its pharmacokinetic study in rats

[3] Tetsuo Tamura, et al. Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan

[4] Carles Villabona. Vasopressin receptor antagonists: the vaptans

[5] No authors listed. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome

Related Vasopressin Receptor Products
d[Cha4]-AVP

d[Cha4]-AVP is a potent and selective vasopressin (AVP) V1b receptor agonist with a Ki of 1.2 nM for human V1b receptor.

Big Endothelin-1 (1-38), human

Big Endothelin-1 (1-38), human is the precursor of endothelin-1.

(d(CH2)51, Tyr(Me)2, Arg8)-Vasopressin

(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin (SKF 100273) is a vasopressin V1 receptor selective antagonist.

[Asu1, 6-Arg8]Vasopressin

[Asu1,6-Arg8]Vasopressin is an vasopressin agonist which potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor (CRF) in rat anterior pituitary cells in culture.

Big Endothelin-1 (1-39), porcine

Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mozavaptan, OPC-31260 supplier, Vasopressin Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.